Overview
Our Commitment
Adamas develops novel therapeutics for the treatment of central nervous system (CNS) disorders. About Adamas
Product Pipeline
Product Pipeline
We have developed a portfolio of CNS therapeutics. Our Pipeline
ADS-5102 in LID
Why Aminoadamantanes?
Submission of New Drug Application (NDA) to FDA targeted in 2016. Learn More